As everyone who follows this show knows, Pete and Sandra are HUGE fans of IndieBio and the incredible companies that are part of their cohorts, companies that are changing the world as we know it for the better. In this episode we get to sit down with Arvind Gupta, founder of IndieBio to learn more about his own founding story and what led him to create a new type of accelerator that has flipped the model for conventional funding, entrepreneurship and development of bio tech innovation.

Stem cell therapy has the power to change lives, and in recent years we’ve heard a lot about its miraculous potential, but unfortunately today it is not a therapy that is accessible to anyone beyond the famous sports stars or the ultra wealthy. Enter the Mini-Stem created by JointechLabs, which essentially is a lab in your hands, it is a small handheld device that can process fat tissue and deliver back one’s own stem cells, eliminating the need for an expensive lab setup.

We sat down with John Butler, CEO of Quantumcyte who has a long history in the biotech world of Silicon Valley, specifically building tools and technology that can answer and solve complex problems effectively.

Before founding Quantumcyte, John held a variety of roles in biotech companies ranging from: Applera research institute  Pacific Biosciences Applied Biosystems to being the Director of Process Development at Stanford University School of Medicine. His co-founder is Dr. Bidhan Chaudhuri.

We all know bees are vital to our survival. Matias Viel CEO of Bee Flow is on the job. He's bridging the gap between the smartest minds working to study bees and the farmers who are desperate for improved healthy, production and intelligence from bees.

Bee Flow is an IndieBio cohort company from the SOSV based accelerator. They are just the latest in batch of companies we are highlighting in the weeks leading up to IndieBio's Spring demo day on April 17th at the Herbst Theater in San Francisco.

Micha Benonial is a serial entrepreneur with a dream to connect the planet in the aim of making knowledge accessible to all humanity. He joins us in this week’s episode of Popping the Bubbl to discuss his entrepreneurial journey and how connecting humans to foster collaboration and knowledge sharing, has always been at the center of what does.

#Podcast #BUBBL

Pete recently had the chance to catch up with Nathan Hirsch, CEO of FreeeUp, a business marketplace for freelance service providers that has managed to realize a pretty amazing trajectory in a short period of time.

How does FreeeUp differ from other marketplaces that exist?  

FreeeUp focuses on the top 1% of freelancers, those with years of experience, a strong command of strong communication practices. These differentiators are ascertained through an extensive vetting process conducted by FreeeUP.

In our latest episode of Popping the Bubbl, we sat down with Ming Zhao of Proven Beauty to discuss her personalized skin care line. Proven Beauty is building the Beauty Genome Project using AI and machine learning processing millions of product reviews from consumers on beauty products and their effectiveness. Using AI, Proven is optimizing the existing data that has been published as well as analyzing product ingredients to develop advanced skin profiles that Proven uses to create custom beauty lines.

Emiliano De Laurantiis, Founder and CEO of Knowledge Avatars joined us in this episode of Popping the Bubbl to share his vision for a new type of learning, one that is personalized to the individual, adaptive, scalable through AI and infinitely more effective because the student becomes an active participant in his or her learning process.

#Podcast #BUBBL #AILearning Pete A Turner, Sandra Ponce De Leon

Melanie Matheu peered into a microscope and saw the future. A time when lasers print organs. Our guests are Co-Founders CEO Melanie Matheu, PhD. & Noelle Mullin, PhD., CSO.

Prellis Biologics is avcompany from the IndieBio accelerator which is tied to SOSV’s efforts to invest in biotech. By their own estimate, transplantable kidneys (or whichever organ they produce first—for this article we’ll use kidneys) will be available in 5 to 8 years.

#tinydinosaurs #alecbaldwin #BUBBL #3dPrinting #printingo

Today on Popping the Bubbl, Sandra and I feature Mike Seldon of Finless Foods. Mike and his co-founder Brian Wyrwas have a dream that I think we can all get behind. The business they are building allows them to make fish protein in a warehouse creating “Clean Fish.” Fish without contaminates, meat that looks, smells, tastes, and feels the same as the finest pieces of fish available in stores, markets and restaurants.

Meat will be grown in labs...and it will change everything.

#BUBBL #Podcast #cleanfi